We previously found evidence of synergistic growth inhibitory and apoptosis-inducing cytotoxic effect of alisertib and carboplatin combination treatment to be selective in high MGMT-expressing GBM cell lines (Sak et al., 2019). The gene discussed is MGMT; the disease is glioblastoma.